Fatty acid oxidation accelerates, particularly in liver tissue where fat accumulation poses significant health risks
[This does not apply to glicentin and oxyntomodulin, since oxyntomodulin is a breakdown product of glicentin
Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P
It can help reduce fat deposits and accelerate metabolic processes
Individualized Dosage Adjustments Each patients response to GLP-1 medications is unique, necessitating dosage adjustments during the weaning process
A qualifying BMI or related health condition is typically required GLP-1 medications like semaglutide are usually prescribed to adults with a BMI over 30, or over 27 if they have a weight-related condition, such as high blood pressure, prediabetes, sleep apnea, or PCOS